Adam J. Townsend Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Adam J. Townsend is Chief Commercial Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 92,453 shares of APLS, which is worth approximately $2.54 Million. The most recent transaction as insider was on Nov 03, 2022, when has been sold 5,000 shares (Common Stock) at a price of $58.54 per share, resulting in proceeds of $292,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92.5K

0% 3M change

21.66% 12M change

Total Value Held $2.54 Million

Adam J. Townsend Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 03 2022	SELL Open market or private sale	$292,700 $58.54 p/Share	5,000 Reduced 10.44%	42,907 Common Stock
Nov 03 2022	SELL Exercise of conversion of derivative security	$75,450 $15.09 p/Share	5,000 Reduced 9.45%	47,907 Common Stock
Oct 03 2022	SELL Open market or private sale	$333,450 $66.69 p/Share	5,000 Reduced 10.44%	42,907 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$75,450 $15.09 p/Share	5,000 Added 9.45%	47,907 Common Stock
Sep 06 2022	SELL Open market or private sale	$301,900 $60.38 p/Share	5,000 Reduced 10.44%	42,907 Common Stock
Sep 06 2022	BUY Exercise of conversion of derivative security	$75,450 $15.09 p/Share	5,000 Added 9.45%	47,907 Common Stock
Aug 15 2022	SELL Open market or private sale	$862,500 $69.0 p/Share	12,500 Reduced 22.56%	42,907 Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	$188,625 $15.09 p/Share	12,500 Added 18.41%	55,407 Common Stock
Aug 11 2022	SELL Open market or private sale	$837,500 $67.0 p/Share	12,500 Reduced 22.56%	42,907 Common Stock
Aug 11 2022	BUY Exercise of conversion of derivative security	$188,625 $15.09 p/Share	12,500 Added 18.41%	55,407 Common Stock
Aug 08 2022	SELL Open market or private sale	$812,500 $65.0 p/Share	12,500 Reduced 22.56%	42,907 Common Stock
Aug 08 2022	BUY Exercise of conversion of derivative security	$188,625 $15.09 p/Share	12,500 Added 18.41%	55,407 Common Stock
Aug 03 2022	SELL Open market or private sale	$282,150 $56.43 p/Share	5,000 Reduced 11.65%	37,907 Common Stock
Aug 03 2022	BUY Exercise of conversion of derivative security	$75,450 $15.09 p/Share	5,000 Added 10.44%	42,907 Common Stock
Jul 11 2022	SELL Open market or private sale	$242,100 $48.42 p/Share	5,000 Reduced 10.44%	42,907 Common Stock
Jul 11 2022	BUY Exercise of conversion of derivative security	$75,450 $15.09 p/Share	5,000 Added 9.45%	47,907 Common Stock
Apr 21 2022	SELL Other acquisition or disposition	-	1,875 Reduced 4.26%	42,138 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$42,172 $47.12 p/Share	895 Reduced 1.99%	44,013 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$30,872 $38.59 p/Share	800 Reduced 1.75%	44,908 Common Stock
Jan 21 2022	BUY Grant, award, or other acquisition	-	26,051 Added 36.3%	45,708 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$32,831 $47.72 p/Share	688 Reduced 3.52%	18,865 Common Stock
Jan 28 2021	BUY Grant, award, or other acquisition	-	9,375 Added 32.41%	19,553 Common Stock

AJT

Adam J. Townsend

Chief Commercial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account